IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
25.61
+0.82 (3.31%)
Dec 20, 2024, 4:00 PM EST - Market closed
IDEAYA Biosciences Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for IDEAYA Biosciences stock have an average target of 53.67, with a low estimate of 27 and a high estimate of 68. The average target predicts an increase of 109.57% from the current stock price of 25.61.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IDYA stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 5 | 5 |
| Buy | 6 | 5 | 5 | 5 | 6 | 7 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 10 | 11 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 17, 2024 |
| Wedbush | Wedbush | Buy Reiterates $52 | Buy | Reiterates | $52 | +103.05% | Dec 17, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $51 | Buy | Initiates | $51 | +99.14% | Nov 18, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $41 → $27 | Buy → Hold | Downgrades | $41 → $27 | +5.43% | Nov 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $53 | Buy | Reiterates | $53 | +106.95% | Oct 29, 2024 |
Financial Forecast
Revenue This Year
4.82M
from 23.39M
Decreased by -79.38%
Revenue Next Year
16.97M
from 4.82M
Increased by 251.89%
EPS This Year
-2.46
from -1.96
EPS Next Year
-2.81
from -2.46
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.5M | 67.9M | 264.7M | |||
| Avg | 4.8M | 17.0M | 60.4M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -55.1% | 1,308.4% | 1,459.9% | |||
| Avg | -79.4% | 251.9% | 255.8% | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.66 | -2.47 | -0.90 | |||
| Avg | -2.46 | -2.81 | -2.78 | |||
| Low | -2.67 | -3.42 | -4.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.